Previous 10 | Next 10 |
10x Genomics to Report Fourth Quarter and Full Year 2023 Financial Results on February 15, 2024 PR Newswire PLEASANTON, Calif. , Jan. 24, 2024 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, today announced ...
2024-01-22 11:29:07 ET More on S&P 500 Index: S&P 500 Sets New Record High As Investors Potentially Shift Focus To Q2 2024 Market Rally Met With Outflows S&P 500: The 'Pump' Is Underway - Watch Out For The 'Dump' S&P won't get the helping hand...
2024-01-20 10:00:00 ET Get ahead of the market by subscribing to Seeking Alpha's Stocks to Watch, a preview of key events scheduled for the coming week. The newsletter keeps you informed of the biggest stories set to make headlines, including upcoming IPOs, investor days, earnings r...
2024-01-20 06:55:00 ET Summary 10x Genomics reported 18% YoY revenue growth in Q4, reaching $184M, with instruments revenue seeing a remarkable surge of 71%. The company celebrated the successful launch of its cutting-edge platform, Xenium, which offers exceptional vision and surp...
2024-01-20 02:20:35 ET Summary 10x Genomics specializes in medical devices and software for analyzing biodata, with impressive revenue growth but struggling to turn a profit. The company's products have been used in over 6,100 medical research publications and have helped create o...
2024-01-19 15:00:29 ET More on the markets SPY Is At Its Highest Risk Level (Technical Analysis) Recession Forecasting: Indicators That Actually Help Your Portfolio (Part 3) New Secular Bull Markets Hidden In Plain Sight Investors retract capital from the fun...
2024-01-18 21:08:20 ET Summary ARK Invest's 13F portfolio value increased by 29% this quarter, reaching approximately $16.89 billion. The top three holdings in the portfolio are Coinbase Global, UiPath, and Tesla. ARK Invest made new stakes in ProShares Bitcoin Strategy ETF an...
2024 is a pivotal year that sets up for strong continued production and future free cash flow from Morelos (All amounts expressed in U.S. dollars unless otherwise stated) Toronto, Ontario--(Newsfile Corp. - January 16, 2024) - Torex Gold Resources Inc. (the "Company" or "Torex") (TSX: TXG) prov...
Production guidance achieved for the fifth consecutive year; Q4 marks second-highest quarter of production to date Toronto, Ontario--(Newsfile Corp. - January 9, 2024) - Torex Gold Resources Inc. (the "Company" or "Torex") (TSX: TXG) reports gold production of 137,993 ounces during the fourth qu...
2024-01-08 12:02:16 ET More on 10x Genomics 10x Genomics: Unveiling The Investment Potential 10x Genomics, Inc. (TXG) Q3 2023 Earnings Call Transcript BofA raises 10x Genomics to buy, cites fading headwinds 10x Genomics files patent lawsuit against rival Curi...
News, Short Squeeze, Breakout and More Instantly...
2024-07-23 06:00:09 ET Kyle Mikson from Canaccord Genuity issued a price target of $32.00 for TXG on 2024-07-23 05:09:00. The adjusted price target was set to $32.00. At the time of the announcement, TXG was trading at $18.11. The overall price target consensus is at $24...
10x Genomics to Report Second Quarter 2024 Financial Results on August 8, 2024 PR Newswire PLEASANTON, Calif. , July 12, 2024 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, today announced that it will report fi...
A look at the top 10 most actives in the United States Kazia Therapeutics Limited (KZIA) rose 248.0% to $0.6682 on volume of 430,252,408 shares Maxeon Solar Technologies Ltd. (MAXN) fell 15.0% to $0.2108 on volume of 237,403,092 shares NVIDIA Corporation (NVDA) rose 2.7% to $134.91 on vol...